{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:46:41Z","timestamp":1791002801747,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7613","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,7,28]]},"DOI":"10.1038\/nature18929","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T15:40:07Z","timestamp":1466610007000},"page":"556-560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":487,"title":["HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption"],"prefix":"10.1038","volume":"535","author":[{"given":"Johannes F.","family":"Scheid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yotam","family":"Bar-On","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Kreider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C. C.","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shimeliovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda Z.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Hadrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Settler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggi","family":"Witmer-Pack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"West,","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Juelg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Keler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hawthorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Zingman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Gulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald H.","family":"Learn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Bjorkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice H.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel C.","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"BFnature18929_CR1","unstructured":"Scheid, J. F. et al. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding. Science, doi:science.1207227 [pii] 10.1126\/science.1207227 (2011)"},{"key":"BFnature18929_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nature07930","volume":"458","author":"JF Scheid","year":"2009","unstructured":"Scheid, J. F. et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458, 636\u2013640, doi:nature07930 [pii] 10.1038\/nature07930 (2009)","journal-title":"Nature"},{"key":"BFnature18929_CR3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1241144","volume":"341","author":"F Klein","year":"2013","unstructured":"Klein, F. et al. Antibodies in HIV-1 vaccine development and therapy. Science 341, 1199\u20131204, doi:10.1126\/science.1241144 (2013)","journal-title":"Science"},{"key":"BFnature18929_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature12744","volume":"503","author":"DH Barouch","year":"2013","unstructured":"Barouch, D. H. et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503, 224\u2013228, doi:10.1038\/nature12744 (2013)","journal-title":"Nature"},{"key":"BFnature18929_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.cell.2014.07.043","volume":"158","author":"A Halper-Stromberg","year":"2014","unstructured":"Halper-Stromberg, A. et al. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell 158, 989\u2013999, doi:10.1016\/j.cell.2014.07.043 (2014)","journal-title":"Cell"},{"key":"BFnature18929_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature11604","volume":"492","author":"F Klein","year":"2012","unstructured":"Klein, F. et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 492, 118\u2013122, doi:10.1038\/nature11604 (2012)","journal-title":"Nature"},{"key":"BFnature18929_CR7","doi-asserted-by":"publisher","first-page":"16538","DOI":"10.1073\/pnas.1315295110","volume":"110","author":"JA Horwitz","year":"2013","unstructured":"Horwitz, J. A. et al. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proceedings of the National Academy of Sciences of the United States of America 110, 16538\u201316543, doi:10.1073\/pnas.1315295110 (2013)","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFnature18929_CR8","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1084\/jem.20132494","volume":"211","author":"M Shingai","year":"2014","unstructured":"Shingai, M. et al. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. J Exp Med 211, 2061\u20132074, doi:10.1084\/jem.20132494 (2014)","journal-title":"J Exp Med"},{"key":"BFnature18929_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature14411","volume":"522","author":"M Caskey","year":"2015","unstructured":"Caskey, M. et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature 522, 487\u2013491, doi:10.1038\/nature14411 (2015)","journal-title":"Nature"},{"key":"BFnature18929_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.aaf0972","volume":"352","author":"T Schoofs","year":"2016","unstructured":"Schoofs, T. et al. HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1. Science 352, 997\u20131001, doi:10.1126\/science.aaf0972 (2016)","journal-title":"Science"},{"key":"BFnature18929_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.aaf1279","volume":"352","author":"CL Lu","year":"2016","unstructured":"Lu, C. L. et al. Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science 352, 1001\u20131004, doi:10.1126\/science.aaf1279 (2016)","journal-title":"Science"},{"key":"BFnature18929_CR12","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1128\/JVI.03136-14","volume":"89","author":"R Kong","year":"2015","unstructured":"Kong, R. et al. Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes. Journal of virology 89, 2659\u20132671, doi:10.1128\/JVI.03136-14 (2015)","journal-title":"Journal of virology"},{"key":"BFnature18929_CR13","doi-asserted-by":"publisher","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","volume":"7","author":"RM Lynch","year":"2015","unstructured":"Lynch, R. M. et al. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Science translational medicine 7, 319ra206, doi:10.1126\/scitranslmed.aad5752 (2015)","journal-title":"Science translational medicine"},{"key":"BFnature18929_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature12746","volume":"503","author":"M Shingai","year":"2013","unstructured":"Shingai, M. et al. Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia. Nature 503, 277\u2013280, doi:10.1038\/nature12746 (2013)","journal-title":"Nature"},{"key":"BFnature18929_CR15","first-page":"E3268","volume":"109","author":"H Mouquet","year":"2012","unstructured":"Mouquet, H. et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proceedings of the National Academy of Sciences of the United States of America 109, E3268\u20133277, doi:10.1073\/pnas.1217207109 (2012)","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFnature18929_CR16","first-page":"E1126","volume":"112","author":"MK Rothenberger","year":"2015","unstructured":"Rothenberger, M. K. et al. Large number of rebounding\/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proceedings of the National Academy of Sciences of the United States of America 112, E1126\u20131134, doi:10.1073\/pnas.1414926112 (2015)","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFnature18929_CR17","doi-asserted-by":"publisher","first-page":"e1004010","DOI":"10.1371\/journal.ppat.1004010","volume":"10","author":"MF Kearney","year":"2014","unstructured":"Kearney, M. F. et al. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy. PLoS pathogens 10, e1004010, doi:10.1371\/journal.ppat.1004010 (2014)","journal-title":"PLoS pathogens"},{"key":"BFnature18929_CR18","doi-asserted-by":"crossref","unstructured":"Kearney, M. F. et al. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses that are Transcriptionally Active Before Stopping Antiretroviral Therapy. Journal of virology, 10.1128\/JVI.02139-15 (2015)","DOI":"10.1128\/JVI.02139-15"},{"key":"BFnature18929_CR19","unstructured":"Salantes, B. S. & B; Bar, Katharine. Potency and Kinetics of Autologous HIV-1 Neutralizing Antibody Responses During ATI. CROI Conference Abstracts Abstract #92 (2016)"},{"key":"BFnature18929_CR20","first-page":"E2083","volume":"109","author":"AP West Jr.","year":"2012","unstructured":"West, A. P., Jr., Diskin, R., Nussenzweig, M. C. & Bjorkman, P. J. Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120. Proceedings of the National Academy of Sciences of the United States of America 109, E2083\u20132090, doi:10.1073\/pnas.1208984109 (2012)","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFnature18929_CR21","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1084\/jem.20130221","volume":"210","author":"R Diskin","year":"2013","unstructured":"Diskin, R. et al. Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies. J Exp Med 210, 1235\u20131249, doi:10.1084\/jem.20130221 (2013)","journal-title":"J Exp Med"},{"key":"BFnature18929_CR22","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1128\/JVI.03608-14","volume":"89","author":"RM Lynch","year":"2015","unstructured":"Lynch, R. M. et al. HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies. Journal of virology 89, 4201\u20134213, doi:10.1128\/JVI.03608-14 (2015)","journal-title":"Journal of virology"},{"key":"BFnature18929_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","volume":"39","author":"T Zhou","year":"2013","unstructured":"Zhou, T. et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity 39, 245\u2013258, doi:10.1016\/j.immuni.2013.04.012 (2013)","journal-title":"Immunity"},{"key":"BFnature18929_CR24","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1126\/science.1245627","volume":"342","author":"D Lyumkis","year":"2013","unstructured":"Lyumkis, D. et al. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 342, 1484\u20131490, doi:10.1126\/science.1245627 (2013)","journal-title":"Science"},{"key":"BFnature18929_CR25","doi-asserted-by":"crossref","unstructured":"Gautam, R. et al. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature, 10.1038\/nature17677 (2016)","DOI":"10.1038\/nature17677"},{"key":"BFnature18929_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nm1244","volume":"11","author":"A Trkola","year":"2005","unstructured":"Trkola, A. et al. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat Med 11, 615\u2013622, doi:10.1038\/nm1244 (2005)","journal-title":"Nat Med"},{"key":"BFnature18929_CR27","doi-asserted-by":"publisher","first-page":"11016","DOI":"10.1128\/JVI.01340-07","volume":"81","author":"S Mehandru","year":"2007","unstructured":"Mehandru, S. et al. Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection. Journal of virology 81, 11016\u201311031, doi:10.1128\/JVI.01340-07 (2007)","journal-title":"Journal of virology"},{"key":"BFnature18929_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho, Y. C. et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540\u2013551, doi:10.1016\/j.cell.2013.09.020 (2013)","journal-title":"Cell"},{"key":"BFnature18929_CR29","first-page":"343","volume":"30","author":"JZ Li","year":"2016","unstructured":"Li, J. Z. et al. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS 30, 343\u2013353, doi:10.1097\/QAD.0000000000000953 (2016)","journal-title":"AIDS"},{"key":"BFnature18929_CR30","doi-asserted-by":"crossref","unstructured":"West, A. P., Jr. Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues. PNAS (2013)","DOI":"10.1073\/pnas.1309215110"},{"key":"BFnature18929_CR31","doi-asserted-by":"publisher","first-page":"e1003398","DOI":"10.1371\/journal.ppat.1003398","volume":"9","author":"GM Laird","year":"2013","unstructured":"Laird, G. M. et al. Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay. PLoS pathogens 9, e1003398, doi:10.1371\/journal.ppat.1003398 (2013)","journal-title":"PLoS pathogens"},{"key":"BFnature18929_CR32","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1097\/QAD.0b013e32832eb285","volume":"23","author":"P Volberding","year":"2009","unstructured":"Volberding, P. et al. Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS 23, 1987\u20131995, doi:10.1097\/QAD.0b013e32832eb285 (2009)","journal-title":"AIDS"},{"key":"BFnature18929_CR33","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1086\/509508","volume":"194","author":"JM Kilby","year":"2006","unstructured":"Kilby, J. M. et al. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024). The Journal of infectious diseases 194, 1672\u20131676, doi:10.1086\/509508 (2006)","journal-title":"The Journal of infectious diseases"},{"key":"BFnature18929_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1086\/506364","volume":"194","author":"JM Jacobson","year":"2006","unstructured":"Jacobson, J. M. et al. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068. The Journal of infectious diseases 194, 623\u2013632, doi:10.1086\/506364 (2006)","journal-title":"The Journal of infectious diseases"},{"key":"BFnature18929_CR35","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1195271","volume":"330","author":"F Pereyra","year":"2010","unstructured":"Pereyra, F. et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330, 1551\u20131557, doi:10.1126\/science.1195271 (2010)","journal-title":"Science"},{"key":"BFnature18929_CR36","first-page":"11","volume":"12","author":"DC Montefiori","year":"2005","unstructured":"Montefiori, D. C. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr Protoc Immunol Chapter 12 , Unit 12 11, doi:10.1002\/0471142735.im1211s64 (2005)","journal-title":"Curr Protoc Immunol"},{"key":"BFnature18929_CR37","doi-asserted-by":"publisher","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","volume":"79","author":"M Li","year":"2005","unstructured":"Li, M. et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. Journal of virology 79, 10108\u201310125, doi:10.1128\/JVI.79.16.10108-10125.2005 (2005)","journal-title":"Journal of virology"},{"key":"BFnature18929_CR38","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JVI.02660-07","volume":"82","author":"JF Salazar-Gonzalez","year":"2008","unstructured":"Salazar-Gonzalez, J. F. et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. Journal of virology 82, 3952\u20133970, doi:10.1128\/JVI.02660-07 (2008)","journal-title":"Journal of virology"},{"key":"BFnature18929_CR39","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","volume":"28","author":"M Kearse","year":"2012","unstructured":"Kearse, M. et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647\u20131649, doi:10.1093\/bioinformatics\/bts199 (2012)","journal-title":"Bioinformatics"},{"key":"BFnature18929_CR40","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1101\/gr.849004","volume":"14","author":"GE Crooks","year":"2004","unstructured":"Crooks, G. E., Hon, G., Chandonia, J. M. & Brenner, S. E. WebLogo: a sequence logo generator. Genome research 14, 1188\u20131190, doi:10.1101\/gr.849004 (2004)","journal-title":"Genome research"},{"key":"BFnature18929_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jviromet.2007.02.015","volume":"143","author":"JL Kirchherr","year":"2007","unstructured":"Kirchherr, J. L. et al. High throughput functional analysis of HIV-1 env genes without cloning. Journal of virological methods 143, 104\u2013111, doi:10.1016\/j.jviromet.2007.02.015 (2007)","journal-title":"Journal of virological methods"},{"key":"BFnature18929_CR42","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/sim.2174","volume":"24","author":"J Xie","year":"2005","unstructured":"Xie, J. & Liu, C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Statistics in medicine 24, 3089\u20133110, doi:10.1002\/sim.2174 (2005)","journal-title":"Statistics in medicine"},{"key":"BFnature18929_CR43","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","volume":"23","author":"MA Larkin","year":"2007","unstructured":"Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947\u20132948, doi:btm404 [pii] 10.1093\/bioinformatics\/btm404 (2007)","journal-title":"Bioinformatics"},{"key":"BFnature18929_CR44","unstructured":"Maddison, W. P. & Maddison, D. R. MacClade - Analysis of Phylogeny and Character Evolution - Version 4. (Sinauer Associates, Inc., 2001)"},{"key":"BFnature18929_CR45","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nmeth.2109","volume":"9","author":"D Darriba","year":"2012","unstructured":"Darriba, D., Taboada, G. L., Doallo, R. & Posada, D. jModelTest 2: more models, new heuristics and parallel computing. Nature methods 9, 772, doi:10.1038\/nmeth.2109 (2012)","journal-title":"Nature methods"},{"key":"BFnature18929_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/sysbio\/syq010","volume":"59","author":"S Guindon","year":"2010","unstructured":"Guindon, S. et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Systematic biology 59, 307\u2013321, doi:10.1093\/sysbio\/syq010 (2010)","journal-title":"Systematic biology"},{"key":"BFnature18929_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/387183a0","volume":"387","author":"TW Chun","year":"1997","unstructured":"Chun, T. W. et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183\u2013188, doi:10.1038\/387183a0 (1997)","journal-title":"Nature"},{"key":"BFnature18929_CR48","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1073\/pnas.1304288110","volume":"110","author":"NF Parrish","year":"2013","unstructured":"Parrish, N. F. et al. Phenotypic properties of transmitted founder HIV-1. Proceedings of the National Academy of Sciences of the United States of America 110, 6626\u20136633, doi:10.1073\/pnas.1304288110 (2013)","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFnature18929_CR49","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/bioinformatics\/btl057","volume":"22","author":"J Maydt","year":"2006","unstructured":"Maydt, J. & Lengauer, T. Recco: recombination analysis using cost optimization. Bioinformatics 22, 1064\u20131071, doi:10.1093\/bioinformatics\/btl057 (2006)","journal-title":"Bioinformatics"},{"key":"BFnature18929_CR50","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/j.1541-0420.2012.01775.x","volume":"68","author":"EE Giorgi","year":"2012","unstructured":"Giorgi, E. E. & Bhattacharya, T. A note on two-sample tests for comparing intra-individual genetic sequence diversity between populations. Biometrics 68, 1323\u20131326; author reply 1326, doi:10.1111\/j.1541-0420.2012.01775.x (2012)","journal-title":"Biometrics"},{"key":"BFnature18929_CR51","doi-asserted-by":"publisher","first-page":"8541","DOI":"10.1128\/JVI.74.18.8541-8549.2000","volume":"74","author":"MA Altfeld","year":"2000","unstructured":"Altfeld, M. A. et al. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. Journal of virology 74, 8541\u20138549 (2000)","journal-title":"Journal of virology"},{"key":"BFnature18929_CR52","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1128\/JVI.77.3.2081-2092.2003","volume":"77","author":"MM Addo","year":"2003","unstructured":"Addo, M. M. et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. Journal of virology 77, 2081\u20132092 (2003)","journal-title":"Journal of virology"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature18929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature18929","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature18929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T15:20:18Z","timestamp":1650036018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature18929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":52,"journal-issue":{"issue":"7613","published-print":{"date-parts":[[2016,7,28]]}},"alternative-id":["BFnature18929"],"URL":"https:\/\/doi.org\/10.1038\/nature18929","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726445812.793524772","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]},"assertion":[{"value":"12 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are pending patent applications on the 3BNC117 and 10-1074 antibodies by Rockefeller University on which M.C.N. and J.F.S. are inventors. The patents are not licensed by any companies. Neither M.C.N. nor J.F.S. have any competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}